MedPath
HSA Approval

MEI-MEI WORM SYRUP 750 mg/5 ml

SIN02935P

MEI-MEI WORM SYRUP 750 mg/5 ml

MEI-MEI WORM SYRUP 750 mg/5 ml

May 22, 1989

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantCENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Licence HolderCENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

P02CB01

piperazine

Manufacturer Information

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

PIPERAZINE CITRATE EQV PIPERAZINE HYDRATE

750 mg/5 ml

Piperazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEI-MEI WORM SYRUP 750 mg/5 ml - HSA Approval | MedPath